What is it about?

The new bed side test uses non-anticoagulated blood but others do anticoagulated blood.

Featured Image

Why is it important?

The most predominantly used test at present is to measure biomarkers, especially D-dimer. But D-dimer is not useful because D-dimer cannot give subsequent suitable treatments. On the contrary the test using non-anticoagulated blood can do.


This test , Global Thrombosis Test (GTT), will be widely used in the future not only at hospital but in various fields such as agriculture, food company, pharmaceutical company, sports company, dietary company and so on to prevent thrombotic disorders.

Junichiro Yamamoto

Read the Original

This page is a summary of: A point-of-care global thrombosis test measuring occlusion time and endogenous lysis time may indicate thrombotic status, Future Science OA, July 2019, Future Science,
DOI: 10.2144/fsoa-2019-0052.
You can read the full text:



The following have contributed to this page